Literature DB >> 10628815

Deletion of the GPG motif in the HIV type 1 V3 loop does not abrogate infection in all cells.

J Su1, A Palm, Y Wu, S Sandin, S Höglund, A Vahlne.   

Abstract

The three amino acids glycine, proline, and glycine (GPG) constitute a conserved motif at the center of the V3 loop of HIV-1 surface glycoprotein 120. It has been indicated that deletion of this GPG motif is lethal for viral infectivity and abrogates the ability of the virus to form syncytia. In the present work, we studied the effects of GPG deletion on viral infectivity, cell tropism, syncytium formation, and initiation of apoptosis by constructing a mutant provirus based on the infectious clone pBRu-2. Successful infection and replication of GPG-deleted virus were detected in MT-2 cells, although the mutant virus showed lower infectivity. Infection could also be observed in the C8166, C91-PL, Molt-3, and THP-1 cell lines, and in PBMC-derived dendritic cells (DCs), but not in CEM-SS, HUT78, H9, Jurkat, and U937 cell lines or in PBMCs. Mutant virus also induced syncytia and apoptosis in the MT-2 cells. An intact GPG motif is probably necessary for unimpaired induction of fusion in some HIV-1-permissive cells. However, once the virus enters the cells, the GPG sequence does not seem to be indispensable for syncytium formation or apoptosis induction in MT-2 cells. Our data also imply that cell surface molecules other than CD4 and CXCR4 may be involved in entry of the GPG-deleted virus.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10628815     DOI: 10.1089/088922200309584

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  3 in total

1.  Silencing of HIV-1 by AgoshRNA molecules.

Authors:  E Herrera-Carrillo; A Harwig; B Berkhout
Journal:  Gene Ther       Date:  2017-05-29       Impact factor: 5.250

2.  Activity of the small modified amino acid alpha-hydroxy glycineamide on in vitro and in vivo human immunodeficiency virus type 1 capsid assembly and infectivity.

Authors:  Samir Abdurahman; Akos Végvári; Masoud Youssefi; Michael Levi; Stefan Höglund; Elin Andersson; Peter Horal; Bo Svennerholm; Jan Balzarini; Anders Vahlne
Journal:  Antimicrob Agents Chemother       Date:  2008-07-21       Impact factor: 5.191

3.  Novel small synthetic HIV-1 V3 crown variants: CCR5 targeting ligands.

Authors:  Anju Krishnan Anitha; Pratibha Narayanan; Neethu Ajayakumar; Krishnankutty Chandrika Sivakumar; Kesavakurup Santhosh Kumar
Journal:  J Biochem       Date:  2022-09-05       Impact factor: 3.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.